Detalhe da pesquisa
1.
Genomics to select treatment for patients with metastatic breast cancer.
Nature
; 610(7931): 343-348, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071165
2.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207609
3.
Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome.
J Med Genet
; 55(3): 173-180, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070607
4.
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
PLoS Med
; 13(12): e1002201, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027327
5.
Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.
Int J Cancer
; 137(10): 2513-9, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25994408
6.
Germline mutations of inhibins in early-onset ovarian epithelial tumors.
Hum Mutat
; 35(3): 294-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24302632
7.
Disequilibrium between BRCA1 and BRCA2 Circular and Messenger RNAs Plays a Role in Breast Cancer.
Cancers (Basel)
; 15(7)2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046838
8.
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 9(10): 1381-1389, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561451
9.
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
NPJ Breast Cancer
; 8(1): 106, 2022 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117201
10.
Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
Eur J Cancer
; 164: 70-79, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176614
11.
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer.
Ther Adv Med Oncol
; 14: 17588359211070362, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082924
12.
The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements.
J Med Genet
; 47(6): 398-403, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20522429
13.
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial.
Nat Med
; 27(2): 250-255, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462450
14.
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
Eur J Cancer
; 126: 116-124, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931269
15.
Cost-effectiveness evaluation of pre-counseling telephone interviews before face-to-face genetic counseling in cancer genetics.
Fam Cancer
; 17(3): 451-457, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29080081
16.
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378).
Eur J Cancer
; 53: 144-54, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26724641
17.
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor.
Oncotarget
; 7(46): 74448-74459, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27801670
18.
Loss of intrinsic and extrinsic motility of third nerve revealing breast cancer recurrence.
Acta Neurol Belg
; 120(2): 425-427, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869779
19.
Reliability of Prognostic and Predictive Factors Evaluated by Needle Core Biopsies of Large Breast Invasive Tumors.
Am J Clin Pathol
; 144(4): 555-62, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26386076
20.
[Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria]. / Tolérance rénovasculaire du bévacizumab dans le cancer du sein. Valeur pronostique de l'hypertension et de la proteinuria.
Bull Cancer
; 102(11): 906-14, 2015 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-26603517